Kwality Pharmaceuticals Ltd — Updates, 30-05-2025: Company Update

Kwality Pharmaceuticals has announced a delay in filing its Annual Secretarial Compliance Report for the year ended March 31, 2024, resulting in a Rs. 2,360 penalty, which has been paid. The company also faced a two-day delay in submitting the annual report for FY2024, triggering a Rs. 4,720 penalty, paid subsequently. A 17-day delay occurred in sending notices to shareholders regarding unclaimed dividends eligible for transfer to the Investor Education and Protection Fund, attributed to technical issues. All other compliance requirements under SEBI regulations, including disclosures, policies, and insider trading norms, have been met without additional penalties or actions.